{"title":"Coronavirus in a patient with hepatitis C: case report","authors":"Lucas R. Mostardeiro, E. Antoniolli, J. W. Xavier","doi":"10.5935/1676-2444.20200059","DOIUrl":"https://doi.org/10.5935/1676-2444.20200059","url":null,"abstract":"ABSTRACT In February 2020, the World Health Organization (WHO) named the infection with the new coronavirus, which appeared in December 2019 in China, as Covid-19, and defined it as a worldwide pandemic There is not much evidence about the relationship between liver disease and Covid-19 Laboratory tests have played a fundamental role in confirming Covid-19, what is usually done by the polymerase chain reaction (PCR) sample The present study reports the laboratory aspects of a patient with type C hepatitis diagnosed with Covid-19 with an unfavorable evolution, devoting special attention to laboratory tests that were almost normal RESUMEN En febrero de 2020, la Organización Mundial de la Salud (OMS) nombró a la infección por el nuevo coronavirus, que surgió en diciembre de 2019 en China, Covid-19, declarándola como pandemia mundial No hay mucha evidencia sobre la relación entre enfermedades hepáticas y la Covid-19 Las pruebas de laboratorio han ocupado un lugar fundamental para confirmar la infección, lo que generalmente se hace por la muestra de reacción en cadena de la polimerasa (PCR) El presente estudio reporta los aspectos de laboratorio de un paciente con hepatitis C y diagnóstico de Covid-19 con evolución desfavorable, llamando la atención sobre pruebas de laboratorio con resultados casi normales RESUMO Em fevereiro de 2020, a Organização Mundial da Saúde (OMS) chamou a infecção pelo novo coronavírus, que surgiu em dezembro de 2019 na China, de COVID-19, definindo-a como pandemia mundial Não há muitas evidências sobre a relação das doenças hepáticas e a COVID-19 Os exames laboratoriais vêm exercendo um papel fundamental na confirmação da infecção, que é feita geralmente pela amostra de reação em cadeia da polimerase (PCR) O presente estudo relata os aspectos laboratoriais de um paciente portador de hepatite do tipo C e diagnóstico de COVID-19 com evolução desfavorável, dando atenção especial para exames laboratoriais que estavam pouco alterados","PeriodicalId":35397,"journal":{"name":"Jornal Brasileiro de Patologia e Medicina Laboratorial","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71117211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Juliana Cristina Magalhães, Leonarda Silvestre Faria de Morais, J. Plewka, M. Turkiewicz, R. Amaral
{"title":"Evaluation of quality indicators of cervical cytopathology tests carried\u0000 out in a municipality of Paraná, Brazil","authors":"Juliana Cristina Magalhães, Leonarda Silvestre Faria de Morais, J. Plewka, M. Turkiewicz, R. Amaral","doi":"10.5935/1676-2444.20200041","DOIUrl":"https://doi.org/10.5935/1676-2444.20200041","url":null,"abstract":"Introduction: Although the criteria and recommendations are well defined to improve the quality of cervical cytopathology tests (Pap smear) in Brazil, the quality indicators of several laboratories are below the recommended standards. Objective: To evaluate the quality indicators of cervical cytopathology tests carried out by the Brazilian Unified Health System [Sistema Único de Saúde (SUS)]. Method: Cross-sectional study based on the results of cervical cytopathology tests conducted in the municipality of Cascavel, Paraná, Brazil, from January 2012 to December 2018. The study included 141,191 tests and the following variables were analyzed: sample suitability, cervical cytopathology tests result, and internal quality monitoring indicators recommended by the Brazilian Ministry of Health. Results: The percentage of unsatisfactory tests did not exceed 0.97%. The representation of the squamocolumnar junction ranged from 63% to 67.4%. The percentage of altered exams among the satisfactory samples ranged from 0.46% to 6.44%. The positivity index ranged from 0.46% to 6.44%, while the high-grade squamous intraepithelial lesion/satisfactory indicator ranged from 0.21% to 1.06%, atypical squamous cells of undetermined significance/altered ranged from 22.47% to 49.93%, atypical squamous cells of undetermined significance/satisfactory ranged from 0.1% to 2.57%: and atypical squamous cells of undetermined significance/squamous intraepithelial lesions ranged from 0.31 to 1.02. Conclusion: In 2012 and 2013, the high-grade squamous intraepithelial lesion/satisfactory and the positivity index indicators were below the recommended parameters, and in the remaining years, these indicators were within the parameters recommended. Consequently, a greater number of truly cancer precursor lesions were identified, demonstrating the importance of internal quality control in the prevention of cervical cancer.","PeriodicalId":35397,"journal":{"name":"Jornal Brasileiro de Patologia e Medicina Laboratorial","volume":"56 1","pages":"1-7"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71116875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}